Flow chemistry specialists Vapourtec have developed the Peptide-Builder, a fully automated, high throughput, benchtop peptide synthesiser, which was launched at the recent TIDES Europe event in Hamburg.

Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis.

SEKISUI Diagnostics’ microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at its UK site for clinical-grade drug substance manufacturing.

Collaboration enhances unprecedented access to deep, unbiased proteomics at scale, enabling deeper insights into human biology.

Nuclera, and Domainex, announced that Domainex is the first contract research organization (CRO) to have installed the eProtein Discovery system and offer protein production services using the technology.

Alfa Chemistry is delighted to announce the launch of its much-anticipated Scholarship Program 2024, aimed at supporting and empowering chemistry-related college students.